Dynocardia develops the ViTrack™ platform, a wrist-wearable device that provides continuous, beat-to-beat blood pressure monitoring along with vital heart and lung function data. This technology addresses the need for accurate and real-time health monitoring in various settings, including hospitals and remote patient care.
Funding
$675.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for blood pressure monitoring often rely on intermittent measurements taken in clinical settings, which may not accurately reflect a patient's true blood pressure fluctuations throughout the day. This can lead to delayed or inaccurate diagnoses and suboptimal management of hypertension and other cardiovascular conditions.
Solution
Dynocardia's ViTrack™ platform offers a solution through a wrist-worn wearable device that enables continuous, beat-to-beat blood pressure monitoring, along with comprehensive data on heart and lung function. This technology provides real-time insights into a patient's cardiovascular health, allowing for more informed clinical decision-making and personalized treatment plans. The ViTrack™ platform is designed to be fundamentally distinct from existing monitoring technologies, offering a more accurate and continuous assessment of vital signs.
Target Audience
The primary target audience includes healthcare providers in hospitals and clinical practices, as well as individuals requiring remote patient monitoring and those focused on consumer wellness and disease prevention.
Features
- Continuous, beat-to-beat blood pressure monitoring via a wrist-worn wearable device
- Real-time data on heart and lung function
- Proprietary technology platform distinct from existing monitoring technologies
- Potential applications in hospital, clinical practice, remote patient monitoring, consumer wellness, and disease prevention settings